Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127068) titled 'Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Beykent
Condition:
Omega 3 Fatty Acids
Coronary Arterial Disease (CAD)
Chronic Kidney Disease(CKD)
Intervention:
Dietary Supplement: Omega-3 Suplementation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 1, 2024
Target Sample Size...